Recordati Sets 2026 Financial Calendar and Indicative Dividend Timetable

The latest update is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).

Recordati S.p.A. has published its 2026 corporate events calendar, detailing Board of Directors meetings to approve preliminary 2025 results in February, full-year 2025 accounts in March, and quarterly and half-yearly financial reports in May, July and November, each followed by conference calls with the financial community. The company also set indicative dates for dividend payments, with the final dividend for the 2025 financial year scheduled for 20 May 2026 and an interim 2026 dividend slated for 25 November 2026, while clarifying that these timings do not guarantee that distribution conditions will be met and that any changes to the timetable will be promptly communicated to the market.

The most recent analyst rating on (IT:REC) stock is a Sell with a EUR48.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati S.p.A. is an international pharmaceutical group listed on Borsa Italiana, originating from a family-run pharmacy in Northern Italy in the 1920s. The company develops, produces, markets and licenses active pharmaceutical ingredients and finished drugs, offering therapies in both general and specialist medicine as well as rare diseases. Operating in around 150 countries across EMEA, the Americas and APAC with more than 4,580 employees, Recordati focuses on addressing the needs of patients with common and rare conditions through a fully integrated pharmaceutical value chain.

Average Trading Volume: 299,183

Technical Sentiment Signal: Hold

Current Market Cap: €9.76B

Find detailed analytics on REC stock on TipRanks’ Stock Analysis page.